Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-08-05 Purchase(A) | 2026-08-28 5:38 pm | Attovia Therapeutics Inc. | ATTO | WALSH COLIN Director | 585,000 | $17.58 | $10,285,000 | 3,392,705 (Indirect) | View |
| 2026-08-05 Sale(A) | 2026-08-28 5:38 pm | Attovia Therapeutics Inc. | ATTO | WALSH COLIN Director | 105,807 | $21.28 | $2,251,658 | 3,392,705 (Indirect) | View |
| 2026-08-05 Purchase(A) | 2026-08-28 5:38 pm | Attovia Therapeutics Inc. | ATTO | GOLDMAN SACHS GROUP INC GOLDMAN SACHS & CO. LLC GOLDMAN SACHS ASSET MANAGEMENT L.P. Broad Street Principal Investments L.L.C. WSLS OFFSHORE INVESTMENTS SLP West Street Life Sciences I L.P. WSLS EMP OFFSHORE INVESTMENTS L.P. WSLS EMP ONSHORE INVESTMENTS L.P. Former 10% Owner | 585,000 | $17.58 | $10,285,000 | 3,392,705 (Indirect) | View |
| 2026-08-05 Sale(A) | 2026-08-28 5:38 pm | Attovia Therapeutics Inc. | ATTO | GOLDMAN SACHS GROUP INC GOLDMAN SACHS & CO. LLC GOLDMAN SACHS ASSET MANAGEMENT L.P. Broad Street Principal Investments L.L.C. WSLS OFFSHORE INVESTMENTS SLP West Street Life Sciences I L.P. WSLS EMP OFFSHORE INVESTMENTS L.P. WSLS EMP ONSHORE INVESTMENTS L.P. Former 10% Owner | 105,807 | $21.28 | $2,251,658 | 3,392,705 (Indirect) | View |
| 2026-08-05 Purchase | 2026-08-13 9:52 pm | Attovia Therapeutics Inc. | ATTO | WALSH COLIN Director | 585,000 | $17.58 | $10,285,000 | 3,020,632 (Indirect) | View |
| 2026-08-05 Sale | 2026-08-13 9:52 pm | Attovia Therapeutics Inc. | ATTO | WALSH COLIN Director | 105,807 | $21.28 | $2,251,658 | 3,020,632 (Indirect) | View |
| 2026-08-05 Purchase | 2026-08-13 9:51 pm | Attovia Therapeutics Inc. | ATTO | GOLDMAN SACHS GROUP INC GOLDMAN SACHS & CO. LLC GOLDMAN SACHS ASSET MANAGEMENT L.P. Broad Street Principal Investments L.L.C. WSLS OFFSHORE INVESTMENTS SLP West Street Life Sciences I L.P. WSLS EMP OFFSHORE INVESTMENTS L.P. WSLS EMP ONSHORE INVESTMENTS L.P. Former 10% Owner | 585,000 | $17.58 | $10,285,000 | 3,020,632 (Indirect) | View |
| 2026-08-05 Sale | 2026-08-13 9:51 pm | Attovia Therapeutics Inc. | ATTO | GOLDMAN SACHS GROUP INC GOLDMAN SACHS & CO. LLC GOLDMAN SACHS ASSET MANAGEMENT L.P. Broad Street Principal Investments L.L.C. WSLS OFFSHORE INVESTMENTS SLP West Street Life Sciences I L.P. WSLS EMP OFFSHORE INVESTMENTS L.P. WSLS EMP ONSHORE INVESTMENTS L.P. Former 10% Owner | 105,807 | $21.28 | $2,251,658 | 3,020,632 (Indirect) | View |
| 2026-08-06 Purchase | 2026-08-10 4:12 pm | Attovia Therapeutics Inc. | ATTO | venBio Global Strategic Fund IV L.P. 10% Owner | 382,352 | $17 | $6,499,984 | 4,181,367 (Direct) | View |
| 2026-08-06 Purchase | 2026-08-07 9:47 pm | Attovia Therapeutics Inc. | ATTO | Redmile Group LLC Green Jeremy Redmile Biopharma Investments III L.P. 10% Owner | 600,000 | $17 | $10,200,000 | 2,165,708 (Indirect Direct) | View |
| 2026-08-06 Purchase | 2026-08-07 3:45 pm | Attovia Therapeutics Inc. | ATTO | Sanofi 10% Owner | 300,000 | $17 | $5,100,000 | 1,082,855 (Indirect) | View |
| 2026-08-06 Purchase | 2026-08-06 5:35 pm | Attovia Therapeutics Inc. | ATTO | Frazier Life Sciences XI L.P. FHMLS XI L.P. FHMLS XI L.L.C. 10% Owner | 588,235 | $17 | $9,999,995 | 6,154,213 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-08-06 Conversion(A) | 2026-08-28 5:38 pm | N/A N/A | Attovia Therapeutics Inc. | ATTO | WALSH COLIN Director | 25,062,737 | $0 | 3,392,705 (Indirect) | View |
| 2026-08-06 Conversion(A) | 2026-08-28 5:38 pm | N/A N/A | Attovia Therapeutics Inc. | ATTO | GOLDMAN SACHS GROUP INC GOLDMAN SACHS & CO. LLC GOLDMAN SACHS ASSET MANAGEMENT L.P. Broad Street Principal Investments L.L.C. WSLS OFFSHORE INVESTMENTS SLP West Street Life Sciences I L.P. WSLS EMP OFFSHORE INVESTMENTS L.P. WSLS EMP ONSHORE INVESTMENTS L.P. Former 10% Owner | 25,062,737 | $0 | 3,392,705 (Indirect) | View |
| 2026-08-06 Conversion | 2026-08-13 9:52 pm | N/A N/A | Attovia Therapeutics Inc. | ATTO | WALSH COLIN Director | 25,062,737 | $0 | 3,020,632 (Indirect) | View |
| 2026-08-06 Conversion | 2026-08-13 9:51 pm | N/A N/A | Attovia Therapeutics Inc. | ATTO | GOLDMAN SACHS GROUP INC GOLDMAN SACHS & CO. LLC GOLDMAN SACHS ASSET MANAGEMENT L.P. Broad Street Principal Investments L.L.C. WSLS OFFSHORE INVESTMENTS SLP West Street Life Sciences I L.P. WSLS EMP OFFSHORE INVESTMENTS L.P. WSLS EMP ONSHORE INVESTMENTS L.P. Former 10% Owner | 25,062,737 | $0 | 3,020,632 (Indirect) | View |
| 2026-08-06 Conversion | 2026-08-10 4:30 pm | N/A N/A | Attovia Therapeutics Inc. | ATTO | Deep Track Biotechnology Master Fund Ltd. Deep Track Capital LP KROIN DAVID 10% Owner | 20,138,956 | $0 | 1,957,138 (Direct) | View |
| 2026-08-06 Conversion | 2026-08-10 4:12 pm | N/A N/A | Attovia Therapeutics Inc. | ATTO | venBio Global Strategic Fund IV L.P. 10% Owner | 39,091,869 | $0 | 4,181,367 (Direct) | View |
| 2026-08-06 Conversion | 2026-08-07 9:47 pm | N/A N/A | Attovia Therapeutics Inc. | ATTO | Redmile Group LLC Green Jeremy Redmile Biopharma Investments III L.P. 10% Owner | 782,854 | $0 | 2,165,708 (Indirect) | View |
| 2026-08-06 Conversion | 2026-08-07 3:45 pm | N/A N/A | Attovia Therapeutics Inc. | ATTO | Sanofi 10% Owner | 782,855 | $0 | 1,082,855 (Indirect) | View |
| 2026-08-06 Conversion | 2026-08-06 5:35 pm | N/A N/A | Attovia Therapeutics Inc. | ATTO | Frazier Life Sciences XI L.P. FHMLS XI L.P. FHMLS XI L.L.C. 10% Owner | 56,498,585 | $0 | 6,154,213 (Direct) | View |
| 2026-08-04 Option Award | 2026-08-06 5:17 pm | N/A 2036-08-03 | Attovia Therapeutics Inc. | ATTO | You Angie Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2026-08-04 Option Award | 2026-08-06 5:17 pm | N/A 2036-08-03 | Attovia Therapeutics Inc. | ATTO | GOLD MITCHELL Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2026-08-04 Option Award | 2026-08-06 5:16 pm | N/A 2036-08-03 | Attovia Therapeutics Inc. | ATTO | Odrowaz Zaneta Chief Business Officer | 140,000 | $0 | 140,000 (Direct) | View |
| 2026-08-04 Option Award | 2026-08-06 5:15 pm | N/A 2036-08-03 | Attovia Therapeutics Inc. | ATTO | Veiby Petter Chief Scientific Officer | 140,000 | $0 | 140,000 (Direct) | View |
| 2026-08-04 Option Award | 2026-08-06 5:14 pm | N/A 2036-08-03 | Attovia Therapeutics Inc. | ATTO | Chen Hubert Chief Medical Officer | 140,000 | $0 | 140,000 (Direct) | View |
| 2026-08-04 Option Award | 2026-08-06 5:13 pm | N/A 2036-08-03 | Attovia Therapeutics Inc. | ATTO | Attovia Therapeutics Inc. Chief Financial Officer | 140,000 | $0 | 140,000 (Direct) | View |
| 2026-08-04 Option Award | 2026-08-06 5:11 pm | N/A 2036-08-03 | Attovia Therapeutics Inc. | ATTO | Attovia Therapeutics Inc. President and CEO | 538,300 | $0 | 538,300 (Direct) | View |
Ownership | 2026-08-05 7:19 pm | N/A N/A | Attovia Therapeutics Inc. | ATTO | Alamar HoldCo LLC 10% Owner | 0 | $0 | 3,229,278 (Direct) | View |
Ownership | 2026-08-05 6:13 pm | N/A N/A | Attovia Therapeutics Inc. | ATTO | WALSH COLIN Director | 0 | $0 | 2,435,641 (Indirect) | View |
Ownership | 2026-08-04 9:00 pm | N/A N/A | Attovia Therapeutics Inc. | ATTO | Deep Track Biotechnology Master Fund Ltd. Deep Track Capital LP KROIN DAVID 10% Owner | 0 | $0 | 1,957,138 (Direct) | View |
Ownership | 2026-08-04 8:42 pm | N/A N/A | Attovia Therapeutics Inc. | ATTO | Redmile Group LLC Green Jeremy Redmile Biopharma Investments III L.P. 10% Owner | 0 | $0 | 782,854 (Indirect) | View |
Ownership | 2026-08-04 8:00 pm | N/A N/A | Attovia Therapeutics Inc. | ATTO | Vida Ventures GP III L.L.C. Vida Ventures III L.P. Vida Ventures III-A L.P. 10% Owner | 0 | $0 | 939,425 (Indirect) | View |
Ownership | 2026-08-04 7:41 pm | N/A N/A | Attovia Therapeutics Inc. | ATTO | venBio Global Strategic Fund IV L.P. 10% Owner | 0 | $0 | 3,799,015 (Direct) | View |
Ownership | 2026-08-04 7:38 pm | N/A N/A | Attovia Therapeutics Inc. | ATTO | You Angie Director | 0 | $0 | 72,765 (Direct) | View |
Ownership | 2026-08-04 7:36 pm | N/A N/A | Attovia Therapeutics Inc. | ATTO | Veiby Petter Chief Scientific Officer | 0 | $0 | 326,155 (Direct) | View |
Ownership | 2026-08-04 7:34 pm | N/A 2034-11-13 | Attovia Therapeutics Inc. | ATTO | Attovia Therapeutics Inc. Chief Financial Officer | 0 | $0 | 296,016 (Direct) | View |
Ownership | 2026-08-04 7:33 pm | N/A N/A | Attovia Therapeutics Inc. | ATTO | Odrowaz Zaneta Chief Business Officer | 0 | $0 | 311,085 (Direct) | View |
Ownership | 2026-08-04 7:31 pm | N/A N/A | Attovia Therapeutics Inc. | ATTO | Attovia Therapeutics Inc. President and CEO | 0 | $0 | 1,351,988 (Direct) | View |
Ownership | 2026-08-04 7:31 pm | N/A 2034-06-28 | Attovia Therapeutics Inc. | ATTO | GOLD MITCHELL Director | 0 | $0 | 72,765 (Direct) | View |
Ownership | 2026-08-04 7:30 pm | N/A N/A | Attovia Therapeutics Inc. | ATTO | Chen Hubert Chief Medical Officer | 0 | $0 | 296,015 (Direct) | View |
Ownership | 2026-08-04 7:28 pm | N/A 2036-07-01 | Attovia Therapeutics Inc. | ATTO | Smither John W Director | 0 | $0 | 72,792 (Direct) | View |
Ownership | 2026-08-04 7:03 pm | N/A N/A | Attovia Therapeutics Inc. | ATTO | GOLDMAN SACHS GROUP INC GOLDMAN SACHS & CO. LLC GOLDMAN SACHS ASSET MANAGEMENT L.P. Broad Street Principal Investments L.L.C. WSLS OFFSHORE INVESTMENTS SLP West Street Life Sciences I L.P. WSLS EMP OFFSHORE INVESTMENTS L.P. WSLS EMP ONSHORE INVESTMENTS L.P. 10% Owner | 0 | $0 | 2,435,641 (Indirect) | View |
Ownership | 2026-08-04 6:33 pm | N/A N/A | Attovia Therapeutics Inc. | ATTO | Frazier Life Sciences XI L.P. FHMLS XI L.P. FHMLS XI L.L.C. 10% Owner | 0 | $0 | 5,565,978 (Direct) | View |
Ownership | 2026-08-04 5:08 pm | N/A N/A | Attovia Therapeutics Inc. | ATTO | Sanofi 10% Owner | 0 | $0 | 782,855 (Indirect) | View |